Acrylamides with hydrolytically labile carbonate ester side chains as versatile building blocks for well-defined block copolymer micelles via RAFT polymerization

被引:5
作者
Kasmi, Sabah [1 ]
Louage, Benoit [1 ]
Nuhn, Lutz [1 ]
Verstraete, Glenn [1 ]
Van Herck, Simon [1 ]
van Steenbergen, Mies J. [2 ]
Vervaet, Chris [1 ]
Hennink, Wim E. [2 ]
De Geest, Bruno G. [1 ]
机构
[1] Univ Ghent, Dept Pharmaceut, Ghent, Belgium
[2] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, Utrecht, Netherlands
关键词
ANTICANCER DRUG-DELIVERY; CELL LUNG-CANCER; HPMA COPOLYMERS; MACROMOLECULAR THERAPEUTICS; DIBLOCK COPOLYMER; IN-VIVO; PACLITAXEL; CARRIERS; NANOPARTICLES; TUMORS;
D O I
10.1039/c7py01345k
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
En route towards improved delivery systems for targeted chemotherapy, we propose a straightforward approach for the hydrophobic modification of the acrylamide N-(2-Hydroxyethyl) acrylamide (HEAm). An ethyl or benzyl group was introduced via a hydrolytically sensitive carbonate ester yielding HEAm-EC and HEAm-BC, respectively. Block copolymers of HEAm, respectively PEG and HEAm-EC or HEAm-BC were successfully synthesized by reversible addition-fragmentation chain transfer (RAFT) polymerization, obtaining a library of well-defined block copolymers with different degrees of polymerization (DP). To further explore the versatility of our approach in terms of polymer synthesis, self-assembly, drug solubilization and in vitro cell interaction, polyethylene glycol (PEG) and polyHEAm as hydrophilic polymer blocks were compared. The block copolymers formed micellar nanoparticles (10-100 nm) in PBS and could efficiently solubilize hydrophobic dyes and anti-cancer drugs. Benzyl carbonate ester side chains increased micellar stability and drug loading capacity. Moreover, PEG as hydrophilic block showed in comparison to HEAm more promising results concerning both colloidal stability and drug loading capacity. Confocal microscopy showed that the micelles could efficiently deliver a hydrophobic dye inside the cells. Finally, we also demonstrated efficient formulation of the anti-cancer drug paclitaxel with an in vitro cancer cell killing performance comparable or even better than the two commercial PTX nano-formulations Abraxane and Genexol-PM at equal drug dose. In conclusion, modification of HEAm through carbonate linkages offers a versatile platform for the design of degradable polymers with potential for biomedical applications.
引用
收藏
页码:6544 / 6557
页数:14
相关论文
共 42 条
  • [1] Polymeric micelles as drug delivery vehicles
    Ahmad, Zaheer
    Shah, Afzal
    Siddiq, Muhammad
    Kraatz, Heinz-Bernhard
    [J]. RSC ADVANCES, 2014, 4 (33) : 17028 - 17038
  • [2] Well-defined biohybrids using reversible-deactivation radical polymerization procedures
    Averick, Saadyah
    Mehl, Ryan A.
    Das, Subha R.
    Matyjaszewski, Krzysztof
    [J]. JOURNAL OF CONTROLLED RELEASE, 2015, 205 : 45 - 57
  • [3] Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]
  • [4] Progress of drug-loaded polymeric micelles into clinical studies
    Cabral, Horacio
    Kataoka, Kazunori
    [J]. JOURNAL OF CONTROLLED RELEASE, 2014, 190 : 465 - 476
  • [5] Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: Promises, progress and prospects
    Deng, Chao
    Jiang, Yanjiao
    Cheng, Ru
    Meng, Fenghua
    Zhong, Zhiyuan
    [J]. NANO TODAY, 2012, 7 (05) : 467 - 480
  • [6] The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
    Fang, Jun
    Nakamura, Hideaki
    Maeda, Hiroshi
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (03) : 136 - 151
  • [7] Ab initio emulsion polymerization by RAFT-controlled self-assembly
    Ferguson, CJ
    Hughes, RJ
    Nguyen, D
    Pham, BTT
    Gilbert, RG
    Serelis, AK
    Such, CH
    Hawkett, BS
    [J]. MACROMOLECULES, 2005, 38 (06) : 2191 - 2204
  • [8] NANOCAPSULE FORMATION BY INTERFACIAL POLYMER DEPOSITION FOLLOWING SOLVENT DISPLACEMENT
    FESSI, H
    PUISIEUX, F
    DEVISSAGUET, JP
    AMMOURY, N
    BENITA, S
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (01) : R1 - R4
  • [9] Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
    Gelderblom, H
    Verweij, J
    Nooter, K
    Sparreboom, A
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (13) : 1590 - 1598
  • [10] Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs
    Gothwal, Avinash
    Khan, Iliyas
    Gupta, Umesh
    [J]. PHARMACEUTICAL RESEARCH, 2016, 33 (01) : 18 - 39